Human Pharmacology of the methamphetamine stereoisomers
暂无分享,去创建一个
P. Jacob | Reese T. Jones | John Mendelson | J. Mendelson | Naoto Uemura | Debra Harris | Rajneesh P Nath | Emilio Fernandez | Peyton Jacob | E Thomas Everhart | Reese T Jones | N. Uemura | D. Harris | E. Everhart | R. Nath | E. Fernández
[1] A. Beckett,et al. The effect of N‐alkyl chain length and stereochemistry on the absorption, metabolism and urinary excretion of N‐alkylamphetamines in man * , 1973, The Journal of pharmacy and pharmacology.
[2] A. Jeffcoat,et al. Clinical effects of methamphetamine vapor inhalation. , 1991, Life sciences.
[3] F. Vollenweider,et al. The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3, 4-methylenedioxymethamphetamine (‘Ecstasy’) in healthy volunteers , 2000, Journal of psychopharmacology.
[4] D. Mckenna,et al. 3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine , 1991, Pharmacology Biochemistry and Behavior.
[5] F. Vollenweider,et al. Psychological and Physiological Effects of MDMA (“Ecstasy”) after Pretreatment with the 5-HT2 Antagonist Ketanserin in Healthy Humans , 2000, Neuropsychopharmacology.
[6] J. Mendelson,et al. Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans , 2002, Psychopharmacology.
[7] B. Sadler,et al. Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride. , 1993, Drug metabolism and disposition: the biological fate of chemicals.
[8] Reese T. Jones,et al. The bioavailability of intranasal and smoked methamphetamine , 2003, Clinical pharmacology and therapeutics.
[9] B. Sadler,et al. Pharmacokinetics of oral methamphetamine and effects of repeated daily dosing in humans. , 1992, Drug metabolism and disposition: the biological fate of chemicals.
[10] R. E. Hicks,et al. Clinical effects of daily methamphetamine administration. , 1991, Clinical neuropharmacology.
[11] Suneel K. Gupta,et al. Dose‐Proportional and Stereospecific Pharmacokinetics of Methylphenidate Delivered Using an Osmotic, Controlled‐Release Oral Delivery System , 2000, Journal of clinical pharmacology.
[12] G. W. Moore,et al. Determination of therapeutic blood levels of methamphetamine and pentobarbital by GC. , 1971, Journal of pharmaceutical sciences.
[13] R. Watson,et al. Heart disease, methamphetamine and AIDS. , 2003, Life sciences.
[14] W Melega,et al. Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[15] R. Rothman,et al. Monoamine transporters and psychostimulant drugs. , 2003, European journal of pharmacology.
[16] K. Rice,et al. Amphetamine‐type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin , 2001, Synapse.
[17] I. Creese. Stimulants, neurochemical, behavioral, and clinical perspectives , 1983 .
[18] F. Castellanos,et al. Differential effects of amphetamine isomers on dopamine release in the rat striatum and nucleus accumbens core , 2005, Psychopharmacology.
[19] A. Poklis,et al. alpha-benzyl-N-methylphenethylamine (BNMPA), an impurity of illicit methamphetamine synthesis: III. Detection of BNMPA and metabolites in urine of methamphetamine users. , 1996, Journal of analytical toxicology.
[20] D. Segal,et al. Amphetamine and its analogs : psychopharmacology, toxicology, and abuse , 1994 .
[21] Donald F. Smith. CRC handbook of stereoisomers : drugs in psychopharmacology , 1984 .
[22] T. Vree. Pharmacokinetics and metabolism of amphetamines , 1973 .
[23] Lon-Mu Liu,et al. Impacts of federal ephedrine and pseudoephedrine regulations on methamphetamine-related hospital admissions. , 2003, Addiction.
[24] D. F. Neri,et al. Chronopharmacokinetics and Chronopharmacodynamics of Dextromethamphetamine in Man , 1996, Journal of clinical pharmacology.
[25] C. Spielberger,et al. Manual for the state-trait anxiety inventory (form Y) : "self-evaluation questionnaire" , 1983 .
[26] O. Wolkowitz,et al. Altering Cortisol Level does not Change the Pleasurable Effects of Methamphetamine in Humans , 2003, Neuropsychopharmacology.
[27] E. Änggård,et al. Pharmacokinetic studies with amphetamines-relationship to neuropsychiatric disorders , 1973, Journal of Pharmacokinetics and Biopharmaceutics.
[28] A. Beckett,et al. The amphetamines: clinical and pharmacokinetic implications of recent studies of an assay procedure and urinary excretion in man. , 1966, Arzneimittel-Forschung.
[29] G. Koob. Drugs of abuse: anatomy, pharmacology and function of reward pathways. , 1992, Trends in pharmacological sciences.
[30] Reese T. Jones,et al. Methamphetamine and ethanol interactions in humans , 1995, Clinical pharmacology and therapeutics.
[31] B. Logan,et al. Methamphetamine - Effects on Human Performance and Behavior. , 2002, Forensic science review.
[32] Frank T Peters,et al. Drug testing in blood: validated negative-ion chemical ionization gas chromatographic-mass spectrometric assay for determination of amphetamine and methamphetamine enantiomers and its application to toxicology cases. , 2002, Clinical chemistry.
[33] M. Huestis,et al. Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers. , 2003, Clinical chemistry.
[34] M. Mayersohn,et al. Influence of activated charcoal on the disposition kinetics of methamphetamine enantiomers in the rat following intravenous dosing. , 1996, Journal of pharmaceutical sciences.
[35] A. Kurosu,et al. Interpretation and enantiomer analysis of methamphetamine abusers' urine and illegally brewed methamphetamine crystals. , 2000, Journal of analytical toxicology.
[36] A. Buss,et al. An inventory for assessing different kinds of hostility. , 1957, Journal of consulting psychology.
[37] W. Gentry,et al. Disposition of methamphetamine and its metabolite amphetamine in brain and other tissues in rats after intravenous administration. , 2000, The Journal of pharmacology and experimental therapeutics.
[38] A. Beck,et al. An inventory for measuring depression. , 1961, Archives of general psychiatry.